by Karl Denninger
It’s science-loaded — and met with extreme resistance to publication.
Note carefully that the cost to the person who is given this path of treatment for metabolic syndrome (which incidentally either is associated with or leads to Type II diabetes!) is zero.
There were no drugs involved. There is thus no sale of drugs involved, and no profit for the medical industry; indeed, study participants reduced their pre-existing use of pharmaceuticals.